Risk Stratification in Differentiated Thyroid Cancer: New Aspects and Pratical Implementation
R. Michael Tuttle, MD, Endocrinologist, Memorial Sloan-Kettering Cancer Center, New York, New York, Professor, Cornell School of Medicine
Upon completion of this session, participants will improve their competence and performance by being able to: Describe the new 8th edition AJCC/TNM staging system for differentiated thyroid cancer. Describe how to integrate the ATA risk of recurrence stratification system into the 8th edition AJCC staging system. Describe a practical approach to initial risk stratification that can be easily applied in routine clinical practice.
For more information contact:
Department of Medicine/Endocrinology and Diabetes